In HNSCC patients, LAG-3 levels in peripheral blood exhibit a negative correlation with ADAM10, an enzyme that can cleave LAG-3 from the cell surface, implying a tight regulatory control of LAG-3 by ADAM-mediated ectodomain shedding. The gene discussed is LAG3; the disease is head and neck squamous cell carcinoma.